![Anders Larnholt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Anders Larnholt
Plus aucun poste en cours
Fortune : 229 979 $ au 31/07/2026
Profil
Anders Larnholt was the founder of Mallax Pharmaceuticals AB, serving as Head-Mergers & Acquisitions from 2020 to 2022.
Formerly, worked at Meda AB as VP-Corporate Development & Investor Relations from 2010 to 2013.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
MedCap AB
 MedCap AB Medical SpecialtiesHealth Technology Manufactures and sells radiological & ECG equipment, probiotics and nutritional supplements 0,03 % | 09/02/2026 | 4 000 ( 0,03 % ) | 229 979 $ | 31/07/2026 |
Anciens postes connus de Anders Larnholt
| Sociétés | Poste | Fin |
|---|---|---|
Mallax Pharmaceuticals AB
 Mallax Pharmaceuticals AB Financial ConglomeratesFinance Operates as investment company | Fondateur | 01/12/2022 |
| MEDA AB | Investor Relations Contact | 26/11/2013 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
1
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Meda AB
 Meda AB Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Mallax Pharmaceuticals AB
Mallax Pharmaceuticals AB Financial ConglomeratesFinance Operates as investment company | Finance |
